Vision and Mission
Team and Partners
For whom we work


Human flu by virus Influenza A(H1N1): update n° 6
25 July 2009 | News
The worldwide dissemination of the virus Influenza A(H1N1) is more rapid than anticipated. Its impact in countries such as Switzerland is thought to be mostly socioeconomic.

Human flu by the virus Influenza A(H1N1): update n° 5
13 June 2009 | News
The pandemic due to Influenza A(H1N1) is presently progressing, particularly in the Southern hemisphere. However, the viral virulence is weak. Concerning, Switzerland, no additional prevention measures need to be taken in the short term. Anticipating that a second Influenza A(H1N1) flu wave will probably occur in autumn, vaccination of risk groups with the new vaccine presently under production will have to be implemented.

Human flu A/H1N1: update n° 4
3 May 2009 | News
The A/H1N1 virus epidemic is expanding but the situation is not presently dramatic. The virus seems to be of swine genetic origin.

Human flu A/H1N1: update n° 3
30 April 2009 | News
The Word Health Organisation (WHO) raised the alert level from 4 to 5.

Human swine flu A/H1N1: update n° 2
28 April 2009 | News
The Word Health Organisation (WHO) raised the alert level from 3 to 4.

Human swine flu A/H1N1: update n° 1
26 April 2009 | News
The swine flu A/H1N1 outbreak seems to be progressing. However, knowledge on the virus is progressing as well.

Swine influenza in Mexico and North America: the beginning of a pandemic?
25 April 2009 | News
A new swine influenza virus is occurring among humans in Mexico and the United States. It might be potentially pandemic. The epidemiological and biological data which are being collected will allow shortly clarifying the situation.

Rebound of the measles outbreak in Switzerland
13 February 2009 | News
A measles resurgence is being observed in Switzerland since the beginning 2009. About 50 new measles cases have been reported, particularly among people not favourable or even opposing vaccinations. Interlifescience takes this opportunity to remind that vaccination against measles is essential to induce in children an efficient protection against this viral disease and its complications.

Pandemic preparedness and business continuity plan
22 August 2008 | News
According to the WHO (World Health Organisation) the world is in the pandemic alert phase 3. This is the best moment to develop a business continuity plan

Pandemic threat and business continuity plan
13 March 2008 | News
Many Swiss Cantons, including Ticino, have now a preparedness plan in case of pandemic. Should such an event occur in the near future, Interlifescience is ready to help private companies to elaborate their own preparedness plan and to develop a continuity business plan.

Pages: 0 | 10 | 20
Appeal to the Swiss Federal Council for an innovative financing model for the research on new antimicrobials
26 November 2017

On 9 November 2017, the Round Table on Antibiotics launched an appeal to the Federal Council to establish a dialogue in Switzerland between all partners involved in antibiotic research (academic research, economics, small and medium-sized enterprises, pharmaceutical industry, etc.). This dialogue should aim at defining, developing and implementing an innovative financing model for the research, development and marketing of new antibiotics that are financially accessible to all.

The text of the call of November 9, 2017 can be seen under "Publications"

The World Antibiotic Awareness Week will be held on 13-19 November 2017. Switzerland will participate.
8 November 2017

With the purpose of raising awareness of antibiotic resistance and improving the prudent use of antimicrobials, WHO (World Health Organisation) is organising a World Antibiotic Awareness Week since 2015. This year the event will be held from November 13 to 19. For the first time, Switzerland will actively participate to this week. Indeed, the crisis of bacterial resistance to antibiotics is such that an increasing number of infections is becoming difficult to treat, or even impossible. WHO is deeply concerned with this issue and is stimulating its state members to organise campaigns at the national level. Switzerland has already reacted to the antibiotic resistance issue by promoting a National Research Programme of 20 millions CHF(NRP 72) as well as a national Strategy on antibiotic resistance (StAR).

Additional information: StAR NRP72

FEMS 2017, the European microbiology congress, will be held in Valencia, Spain, July 9-13, 2017
29 December 2016

FEMS 2017, the 7th congress of FEMS (Federation of European Microbiological Societies) will be hosted by the Spanish Society for Microbiology (SEM). More than 2’000 participants from all over the world are expected in Valencia from July 9 to 13 to attend this event, which is offering 6 plenary lectures, 32 symposia, 24 workshops, poster discussion sessions, and several special events such as how to publish a paper, or from research to start-up creation, or education. All the domains of microbiology will be considered, including basic and applied research, environment and medical microbiology, microbial cell structure, genetics, antimicrobial resistance, mycology, virology, food microbiology, bioremediation, climate changes, etc..

Additional information: FEMS 2017

interlifescience   Via San Gottardo 92, 6900 Massagno, Switzerland - T : +41 91 960 05 55 - F : +41 91 960 05 56
ByteCode - informatique libre